Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

KIT exon 11 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

KIT mutation (32)

KIT exon 9 mutation (9)

KIT exon 13 mutation (6)

KIT exon 17 mutation (6)

KIT wild-type (3)

KIT W557_V559delinsF (2)

KIT exon 11 mutation + KIT exon 17 mutation (2)

KIT exon 18 mutation (2)

KIT exon 8 mutation (2)

BRAF G466V + KIT K509Q (1)

KDR Q472H + KIT M541L (1)

KIT M552_V555delMYEV (1)

KIT V559A + KIT N822I (1)

KIT V559_E561del (1)

KIT W557_V559>C (1)

KIT W557_V559>F (1)

KIT exon 11 W557_K558delins (1)

KIT exon 14 mutation (1)

KIT exon 17 mutation + KIT exon 18 mutation (1)

KIT translocation (1)

NR4A3 rearrangement + KIT mutation (1)

KIT rs3733542 (0)

KIT mutation (32)

KIT exon 9 mutation (9)

KIT exon 13 mutation (6)

KIT exon 17 mutation (6)

KIT wild-type (3)

KIT W557_V559delinsF (2)

KIT exon 11 mutation + KIT exon 17 mutation (2)

KIT exon 18 mutation (2)

KIT exon 8 mutation (2)

BRAF G466V + KIT K509Q (1)

KDR Q472H + KIT M541L (1)

KIT M552_V555delMYEV (1)

KIT V559A + KIT N822I (1)

KIT V559_E561del (1)

KIT W557_V559>C (1)

KIT W557_V559>F (1)

KIT exon 11 W557_K558delins (1)

KIT exon 14 mutation (1)

KIT exon 17 mutation + KIT exon 18 mutation (1)

KIT translocation (1)

NR4A3 rearrangement + KIT mutation (1)

KIT rs3733542 (0)

›

KIT exon 11 mutation	Gastric Cancer	KIT exon 11 mutation	Gastric Cancer	imatinib Sensitive: B - Late Trials imatinib Sensitive : B	imatinib Sensitive: B - Late Trials imatinib Sensitive : B
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	regorafenib Sensitive: B - Late Trials regorafenib Sensitive : B	regorafenib Sensitive: B - Late Trials regorafenib Sensitive : B
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	imatinib Sensitive: C2 – Inclusion Criteria imatinib Sensitive : C2	imatinib Sensitive: C2 – Inclusion Criteria imatinib Sensitive : C2
KIT exon 11 mutation	Melanoma	KIT exon 11 mutation	Melanoma	nilotinib Sensitive: C2 – Inclusion Criteria nilotinib Sensitive : C2	nilotinib Sensitive: C2 – Inclusion Criteria nilotinib Sensitive : C2
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	ponatinib Sensitive: C2 – Inclusion Criteria ponatinib Sensitive : C2	ponatinib Sensitive: C2 – Inclusion Criteria ponatinib Sensitive : C2
KIT exon 11 mutation	Melanoma	KIT exon 11 mutation	Melanoma	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3
KIT exon 11 mutation	Melanoma	KIT exon 11 mutation	Melanoma	sunitinib Sensitive: C3 – Early Trials sunitinib Sensitive : C3	sunitinib Sensitive: C3 – Early Trials sunitinib Sensitive : C3
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	nilotinib Sensitive: C3 – Early Trials nilotinib Sensitive : C3	nilotinib Sensitive: C3 – Early Trials nilotinib Sensitive : C3
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	sunitinib Sensitive: C3 – Early Trials sunitinib Sensitive : C3	sunitinib Sensitive: C3 – Early Trials sunitinib Sensitive : C3
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3
KIT exon 11 mutation	Gastrointestinal Stromal Tumor	KIT exon 11 mutation	Gastrointestinal Stromal Tumor	avapritinib Resistant: C4 – Case Studies avapritinib Resistant : C4	avapritinib Resistant: C4 – Case Studies avapritinib Resistant : C4
KIT exon 11 mutation	Melanoma	KIT exon 11 mutation	Melanoma	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4